A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer
=================================================================================================================================================

* Lucia D’Amico
* Ulrike Menzel
* Michael Prummer
* Philipp Müller
* Mélanie Buchi
* Abhishek Kashyap
* Ulrike Haessler
* Alexander Yermanos
* Rémy Gébleux
* Manfred Briendl
* Tamara Hell
* Fabian I. Wolter
* Roger R. Beerli
* Iva Truxova
* Špíšek Radek
* Tatjana Vlajnic
* Ulf Grawunder
* Sai Reddy
* Alfred Zippelius